---
title: "Survival Benefits of Sentinel Node Biopsy in Melanoma: Meta-Analysis Findings"
id: "news-news-lancet-oncology-f01c9d44bfb2ee4cfe73c095"
canonical_url: "https://medichelpline.com/news/news-news-lancet-oncology-f01c9d44bfb2ee4cfe73c095"
content_type: "medical_news_article"
category: "Oncology"
source_name: "The Lancet Oncology"
source_url: "https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(26)00026-4/fulltext?rss=yes"
published_at: "2026-03-05T20:55:01.000Z"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Survival Benefits of Sentinel Node Biopsy in Melanoma: Meta-Analysis Findings
## Metadata & Source Attribution
- **Canonical URL:** https://medichelpline.com/news/news-news-lancet-oncology-f01c9d44bfb2ee4cfe73c095
- **Category:** [Oncology](https://medichelpline.com/news/oncology.md)
- **Reporting Source:** The Lancet Oncology
- **Original Source URL:** [Read Original Article](https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(26)00026-4/fulltext?rss=yes)
- **Published At:** 2026-03-05T20:55:01.000Z
## Executive Summary & Key Highlights
A meta-analysis indicates that sentinel node biopsy significantly reduces mortality and recurrence risk in melanoma patients compared to those who do not undergo the procedure.
## In-Depth Reporting & Editorial Analysis
A recent meta-analysis has revealed that melanoma patients who undergo sentinel node biopsy (SNB) experience a significantly lower risk of mortality and recurrence compared to those who do not receive this procedure. These outcomes align with findings from the only existing randomized controlled trial and remained consistent across various sensitivity analyses. This reinforces the conclusion that SNB provides genuine benefits regarding survival and reducing recurrence rates in melanoma cases.
## Navigation
- [← Back to Oncology News](https://medichelpline.com/news/oncology.md)
- [← All Medical News Categories](https://medichelpline.com/news.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.